Korro Bio Company
Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.
Connections from
Last Funding Type:
Series A
Funding Status:
Early Stage Venture
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2018
Total Funding:
91500000
Employee Number:
11-50
Industry:
PharmTech